참고문헌
- Acosta EP, Fletcher CV. Valacyclovir. Ann Pharmacother 1997, 31, 185-191 https://doi.org/10.1177/106002809703100211
- Arnold E, Das K, Ding J, Yadav PN, Hsiou Y, Boyer PL, Hughes SH. Targeting HIV reverse transcriptase for anti-AIDS drug design: structural and biological considerations for chemotherapeutic strategies. Drug Des Discov 1996, 13, 29-47
- Bardsley-Elliot A, Perry CM. Nevirapine: a review of its use in the prevention and treatment of paediatric HIV infection. Paediatr Drugs 2000, 2, 373-407 https://doi.org/10.2165/00128072-200002050-00005
- Beutner KR. Valacyclovir: a review of its antiviral activity, pharmacokinetic properties, and clinical efficacy. Antiviral Res 1995, 28, 281-290 https://doi.org/10.1016/0166-3542(95)00066-6
- Bras AP, Sitar DS, Aoki FY. Comparative bioavailability of acyclovir from oral valacyclovir and acyclovir in patients treated for recurrent genital herpes simplex virus infection. Can J Clin Pharmacol 2001, 8, 207-211
- Dannenfelser RM, He H, Joshi Y, Bateman S, Serajuddin AT. Development of clinical dosage forms for a poorly water soluble drug I: Application of polyethylene glycol-polysorbate 80 solid dispersion carrier system. J Pharm Sci 2004, 93, 1165-1175 https://doi.org/10.1002/jps.20044
- De Clercq E, Field HJ. Antiviral prodrugs - the development of successful prodrug strategies for antiviral chemotherapy. Br J Pharmacol 2006, 147, 1-11 https://doi.org/10.1038/sj.bjp.0706446
- Haase AT. Viral gene expression and pathogenesis in three emerging diseases: HIV and AIDS; HTLV-I and HAM/TSP; and HHV-8 and Kaposi's sarcoma. FEMS Immunol Med Microbiol 1997, 18, 301-305 https://doi.org/10.1111/j.1574-695X.1997.tb01059.x
- Kondo N, Iwao T, Hirai K, Fukuda M, Yamanouchi K, Yokoyama K, Miyaji M, Ishihara Y, Kon K, Ogawa Y, et. al. Improved oral absorption of enteric coprecipitates of a poorly soluble drug. J Pharm Sci 1994, 83, 566-570 https://doi.org/10.1002/jps.2600830425
- Lin JH, Storey DE, Chen IW, Xu X. Improved oral absorption of L-365,260, a poorly soluble drug. Biopharm Drug Dispos 1996, 17, 1-15 https://doi.org/10.1002/(SICI)1099-081X(199601)17:1<1::AID-BDD934>3.0.CO;2-G
-
Lorenzi PL, Landowski CP, Song X, Borysko KZ, Breitenbach JM, Kim JS, Hilfinger JM, Townsend LB, Drach JC, Amidon GL. Amino Acid Ester Prodrugs of 2-Bromo-5,6-dichloro-1-
$\beta$ -D-ribofuranosyl) benzimidazole Enhance Metabolic Stability in Vitro and in Vivo. J Pharmacol Exp Ther 2005, 314, 883-890 https://doi.org/10.1124/jpet.104.082412 -
Song X, Vig BS, Lorenzi PL, Drach JC, Townsend LB, Amidon GL. Amino acid ester prodrugs of the antiviral agent 2-bromo-5,6-dichloro-1-(
$\beta$ -D-ribofuranosyl) benzimidazole as potential substrates of hPEPT1 transporter. J Med Chem 2005, 48, 1274-1277 https://doi.org/10.1021/jm049450i - Sridevi S, Chauhan AS, Chalasani KB, Jain AK, Diwan PV. Enhancement of dissolution and oral, bioavailability of gliquidone with hydroxy propyl-betacyclodextrin. Pharmazie 2003, 58, 807-810
- Sriram D, Yogeeswari P, Srichakravarthy N, Bal TR. Synthesis of stavudine amino acid ester prodrugs with broad-spectrum chemotherapeutic properties for the effective treatment of HIV/AIDS. Bioorg Med Chem Lett 2004, 14, 1085-1087 https://doi.org/10.1016/j.bmcl.2004.01.007
- Subramanian N, Ray S, Ghosal SK, Bhadra R, Moulik SP. Formulation design of self-microemulsifying drug delivery systems for improved oral bioavailability of celecoxib. Biol Pharm Bull 2004, 27, 1993-1999 https://doi.org/10.1248/bpb.27.1993
- Tantillo C, Ding J, Jacobo-Molina A, Nanni RG, Boyer PL, Hughes SH, Pauwels R, Andries K, Janssen PA, Arnold E. Locations of anti-AIDS drug binding sites and resistance mutations in the threedimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol 1994, 243, 369-387 https://doi.org/10.1006/jmbi.1994.1665
- Tashiro K, Ikegawa M, Yabe D, Honjo T. [Anti-HIV-1 genes; genetic restriction of AIDS pathogenesis by gene variants]. Nippon Rinsho 1999, 57, 967-974
- Vig BS, Lorenzi PJ, Mittal S, Landowski CP, Shin HC, Mosberg HI, Hilfinger JM, Amidon GL. Amino acid ester prodrugs of floxuridine: synthesis and effects of structure, stereochemistry, and site of esterification on the rate of hydrolysis. Pharm Res 2003, 20, 1381-1388 https://doi.org/10.1023/A:1025745824632
- Young SD, Britcher SF, Tran LO, Payne LS, Lumma WC, Lyle TA, Huff JR, Anderson PS, Olsen DB, Carroll SS, et. al. L-743, 726 (DMP-266): a novel, highly potent nonnucleoside inhibitor of the human immunodeficiency virus type 1 reverse transcriptase. Antimicrob Agents Chemother 1995, 39, 2602-2605 https://doi.org/10.1128/AAC.39.12.2602